← All Genfit SA filings

Genfit SA 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

GNFT
Genfit SA
20-F: GENFIT S.A. Files 20-F Annual Report, Highlights Iqirvo Approval and Pipeline Progress
GENFIT S.A. releases its 20-F annual report, showcasing the FDA approval of Iqirvo for PBC and advancements in its ACLF and other liver disease programs.
GNFT
Genfit SA
20-F: GENFIT Outlines Equity Incentive Plans in Latest Filing
GENFIT's recent filing details the structure and terms of its equity incentive plans, including stock options and free shares, aimed at aligning employee and executive interests with company performance.